To be used in foods and dietary supplements, ingredients must: be determined to be Generally Recognized as Safe (GRAS), be approved as a New Dietary Ingredient (NDI), be considered an […] Read More >>
  Service(s) related to this article:  Dietary Supplement Consulting, Food Compliance Consulting, New Dietary Ingredients FDA has scheduled a public meeting on October 3, 2017 to discuss developing a list […] Read More >>
The Dietary Supplement Health and Education Act (DSHEA) formed a strong framework for the regulation of New Dietary Ingredient (NDI) notifications as a pre-market safety review process. NDI is defined […] Read More >>
This is an article taken from the official FDA U.S. Food and Drug Administration website. The following is a press announcement from FDA of interest to our Constituent Update subscribers. […] Read More >>
Three final guidance documents and one draft guidance were recently released on FDA nanomaterials regarding the development of nanotechnology in food, dietary supplements, and cosmetic products and reflects FDA’s current […] Read More >>
After three years as the director of FDA’s division of dietary supplements, Dr. Daniel Fabricant, has rejoined the Natural Products Association (NPA) as its CEO. In his first presentation to […] Read More >>
March 26, 2013: dicentra conducted its first webinar of 2013. Critical American and Canadian updates including FDA’s proposed rules to amend cGMPs for food facilities under FSMA, the FDA’s Draft […] Read More >>
FDA considers dietary supplements that contain new dietary ingredients and that have not submitted new dietary ingredient Notifications to be adulterated. Any supplement that is considered to be adulterated can […] Read More >>